PHARMA: McKinell’s over-Exubera-nce

Diabetes sufferers will have to wait a longer for Exubera, an inhaled insulin drug that supporters say transform the lives of people with the condition. Pfizer shares soared this morning after CEO Hank McKinnell said the drug has received FDA approval.

Turns out Mckinnell was just excited…..or perhaps over – Exubera-nt?

Anyway the stock market seems to think that he knows something.



Livongo’s Post Ad Banner 728*90

Categories: Uncategorized

Tagged as: ,

Leave a Reply

1 Comment threads
0 Thread replies
Most reacted comment
Hottest comment thread
1 Comment authors
Pat Salber Recent comment authors
newest oldest most voted
Pat Salber

Have you seen the device that delivers inhaled Exubera?…if you think patients don’t like carrying around syringes and glucometers, wait until they see this thing. I suspect the general diabetes public is going to be less enthusiastic about this product than Wall Street.